tradingkey.logo
tradingkey.logo
Buscar

Hims & Hers Health Inc

HIMS
Añadir a la lista de seguimiento
25.181USD
-3.959-13.58%
Horarios del mercado ETCotizaciones retrasadas 15 min
5.72BCap. mercado
44.13P/E TTM

Hims & Hers Health Inc

25.181
-3.959-13.58%

Más Datos de Hims & Hers Health Inc Compañía

Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. It also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.

Información de Hims & Hers Health Inc

Símbolo de cotizaciónHIMS
Nombre de la empresaHims & Hers Health Inc
Fecha de salida a bolsaSep 09, 2019
Director ejecutivoDudum (Andrew)
Número de empleados1637
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 09
Dirección2269 Chestnut St
CiudadSAN FRANCISCO
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal94123
Teléfono14158510195
Sitio Webhttps://www.forhims.com/
Símbolo de cotizaciónHIMS
Fecha de salida a bolsaSep 09, 2019
Director ejecutivoDudum (Andrew)

Ejecutivos de Hims & Hers Health Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Andrew Dudum
Mr. Andrew Dudum
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
9.53M
-4.23%
Ms. Soleil Boughton
Ms. Soleil Boughton
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
299.37K
-3.16%
Mr. Oluyemi Okupe
Mr. Oluyemi Okupe
Chief Financial Officer
Chief Financial Officer
270.81K
-20.09%
Ms. Christiane Pendarvis
Ms. Christiane Pendarvis
Independent Director
Independent Director
51.77K
--
Mr. Kare Schultz
Mr. Kare Schultz
Independent Director
Independent Director
15.74K
--
Dr. Patrick Carroll, M.D.
Dr. Patrick Carroll, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Dr. Delos Cosgrove, M.D.
Dr. Delos Cosgrove, M.D.
Independent Director
Independent Director
--
--
Ms. Andrea Perez
Ms. Andrea Perez
Independent Director
Independent Director
--
--
Mr. David Wells
Mr. David Wells
Lead Independent Director
Lead Independent Director
--
--
Mr. Mike Chi
Mr. Mike Chi
Chief Operating Officer
Chief Operating Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Andrew Dudum
Mr. Andrew Dudum
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
9.53M
-4.23%
Ms. Soleil Boughton
Ms. Soleil Boughton
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
299.37K
-3.16%
Mr. Oluyemi Okupe
Mr. Oluyemi Okupe
Chief Financial Officer
Chief Financial Officer
270.81K
-20.09%
Ms. Christiane Pendarvis
Ms. Christiane Pendarvis
Independent Director
Independent Director
51.77K
--
Mr. Kare Schultz
Mr. Kare Schultz
Independent Director
Independent Director
15.74K
--
Dr. Patrick Carroll, M.D.
Dr. Patrick Carroll, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de abr
Divisa: USDActualizado: lun., 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
Por negocioUSD
Nombre
Ganancia
Proporción
Online
2.31B
98.46%
Wholesale
36.19M
1.54%
Por regiónUSD
Nombre
Ganancia
Proporción
United States Revenue
2.21B
94.29%
Rest of the World Revenue
133.99M
5.71%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Online
2.31B
98.46%
Wholesale
36.19M
1.54%

Estadísticas de accionistas

Actualizado: dom., 10 de may
Actualizado: dom., 10 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
10.40%
JP Morgan Asset Management
6.74%
Capital World Investors
6.43%
Vanguard Portfolio Management, LLC
4.57%
Goldman Sachs & Company, Inc.
4.38%
Otro
67.48%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
10.40%
JP Morgan Asset Management
6.74%
Capital World Investors
6.43%
Vanguard Portfolio Management, LLC
4.57%
Goldman Sachs & Company, Inc.
4.38%
Otro
67.48%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
49.41%
Investment Advisor/Hedge Fund
12.84%
Research Firm
10.91%
Hedge Fund
6.28%
Individual Investor
5.42%
Bank and Trust
1.84%
Pension Fund
1.83%
Sovereign Wealth Fund
0.86%
Private Equity
0.14%
Otro
10.46%

Participación institucional

Actualizado: mié., 1 de abr
Actualizado: mié., 1 de abr
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q1
1130
208.41M
93.60%
-37.99M
2025Q4
1061
210.10M
95.82%
-8.20M
2025Q3
970
195.39M
89.11%
-889.66K
2025Q2
893
201.00M
92.37%
-34.62M
2025Q1
847
185.19M
85.97%
-48.88M
2024Q4
739
195.19M
91.41%
-9.62M
2024Q3
627
167.49M
80.36%
-35.34M
2024Q2
588
165.89M
79.48%
-12.74M
2024Q1
503
156.70M
75.98%
-10.05M
2023Q4
463
153.90M
75.37%
-26.71M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
23.16M
10.55%
+1.08M
+4.88%
Dec 31, 2025
JP Morgan Asset Management
15.00M
6.83%
+2.13M
+16.55%
Dec 31, 2025
Capital World Investors
14.32M
6.52%
-4.46M
-23.75%
Dec 31, 2025
Goldman Sachs & Company, Inc.
9.76M
4.44%
+1.22M
+14.23%
Dec 31, 2025
Dudum (Andrew)
9.93M
4.52%
-362.12K
-3.52%
Mar 13, 2026
State Street Investment Management (US)
7.31M
3.33%
+132.31K
+1.84%
Dec 31, 2025
Geode Capital Management, L.L.C.
5.51M
2.51%
+608.95K
+12.43%
Dec 31, 2025
Renaissance Technologies LLC
4.82M
2.19%
-4.28M
-47.04%
Dec 31, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
First Trust Nasdaq Lux Digi Health Solutions ETF
3.83%
Global X HealthTech ETF
3.75%
Amplify Weight Loss Drug & Treatment ETF
3.67%
Invesco Dorsey Wright Healthcare Momentum ETF
3.66%
YieldMax Ultra Option Income Strategy ETF
2.96%
Invesco S&P MidCap 400 Pure Growth ETF
2.4%
State Street SPDR S&P Health Care Services ETF
1.94%
Amplify Online Retail ETF
1.85%
Invesco S&P MidCap 400 GARP ETF
1.65%
VanEck Social Sentiment ETF
1.53%
Ver más
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporción3.83%
Global X HealthTech ETF
Proporción3.75%
Amplify Weight Loss Drug & Treatment ETF
Proporción3.67%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporción3.66%
YieldMax Ultra Option Income Strategy ETF
Proporción2.96%
Invesco S&P MidCap 400 Pure Growth ETF
Proporción2.4%
State Street SPDR S&P Health Care Services ETF
Proporción1.94%
Amplify Online Retail ETF
Proporción1.85%
Invesco S&P MidCap 400 GARP ETF
Proporción1.65%
VanEck Social Sentiment ETF
Proporción1.53%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI